"It’s unfortunate Amarin does not feel like letting shareholders know what label they are requesting or anything regarding label discussion, that would help a lot in so many ways."
Right on. We are used to not getting much information from the FDA about anything, but when the company we own shares in locks us out of some information it is truly frustrating. I think it is material and don't know if they would be breaking any FDA application law by divulging that label information with us.
News 
Market Data 
Discover 
